Tag
Granules India Limited
4 articles
Granules India Q2 & H1 FY27 Earnings Call
Granules India schedules an earnings conference call for November 2, 2026, to discuss Q2 and H1 FY27 financial performance.
Management participants include Chairman Dr. Krishna Prasad Chigurupati, Exe
Granules India Board Meeting for Q2 FY27 Results
Granules India Limited will hold its Board meeting on November 2, 2026 to approve unaudited Q2 and half-year results ending September 30, 2026.
The company's insider trading window remains closed unti
Granules India Incorporates Mexican Pharma Subsidiary Triton
Granules India disclosed incorporation of wholly owned foreign subsidiary Triton Farmaceutica S.A. de C.V. in Mexico.
The subsidiary is authorized with 40,000 shares of MX$10.00 each for pharmaceutica
Granules India Promoter Sells 1.72 Crore Shares
Promoter Dr. Krishna Prasad Chigurupati sold 1.72 crore equity shares via block deal and open market on September 11, 2026.
Transaction proceeds will fund the second tranche of the company's ongoing p